Organon to present real-world effectiveness analysis of VTAMA cream in atopic dermatitis at 2026 Fall Clinical Dermatology Conference
OGN•Organon said it will present a real-world analysis of VTAMA cream for atopic dermatitis at a 2026 dermatology conference. The study assessed clinician-reported disease improvement and patient-reported itch relief in routine care.
1. Real-world analysis
Organon flagged an analysis of VTAMA (tapinarof) cream effectiveness in routine care for atopic dermatitis, scheduled for presentation at the 2026 Fall Clinical Dermatology Conference. The study focused on clinician-reported disease improvement and patient-reported itch relief.
